Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2010; 16(42): 5297-5305
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5297
Published online Nov 14, 2010. doi: 10.3748/wjg.v16.i42.5297
Table 2 Ultrasonographic features of the studied groups n (%)
| Variables | Treated group (n = 90) | Control group (n = 50) |
| Liver size | ||
| Average | 27 (30) | 16 (32) |
| Shrunken | 54 (60) | 23 (46) |
| Enlarged | 9 (10) | 11 (22) |
| Liver texture | ||
| Cirrhotic | 90 (100) | 50 (100) |
| Focal lesions | 0 | 0 |
| Spleen | ||
| Average sized | 24 (26.66) | 12 (24) |
| Mild splenomegaly | 48 (53.33) | 29 (58) |
| Moderate splenomegaly | 18 (20) | 9 (18) |
| Huge splenomegaly | 0 | 0 |
| Splenectomy | 0 | 0 |
| Ascites | ||
| Absent | 6 (6.7) | 8 (16) |
| Mild | 12 (13.3) | 5 (10) |
| Moderate | 63 (70) | 32 (64) |
| Massive | 9 (10) | 5 (10) |
- Citation: Salama H, Zekri ARN, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, Mohamed G, Alim SAA, Sherif GM. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010; 16(42): 5297-5305
- URL: https://www.wjgnet.com/1007-9327/full/v16/i42/5297.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i42.5297